This #WorldCancerDay, a reminder that, despite recent advances in the diagnosis and treatment of lung cancer, lung cancer remains the world’s biggest cancer killer.
In 2022, there were 2,480,675 new cases of lung cancer worldwide.[i]
Given the threat lung cancer presents to people and communities across the world, the importance of lung cancer research cannot be understated. It can accelerate the introduction of new and innovative treatments, lead to leaps forward in standards of care, and can significantly improve the experience of patients with lung cancer.
Given the importance of research to the future of patient care, the GLCC has been working with the Institute for Cancer Policy (ICP) since 2015 to better understand the status of lung cancer research globally.
Therefore, to ensure lung cancer research delivers for patients in future the GLCC is calling on all national governments to prioritise the following key actions:
- Protect and invest in lung cancer research programmes
- Publish research spend on lung cancer on an annual basis
- Encourage greater diversity of research by ensuring research programmes account of the needs of patients across their journeys of care
- Prioritise collaboration with global partners to conduct research and share findings to improve patient care.
Read our position document in full: https://tinyurl.com/ek2te8rp
